Source comparison
Does MK-677 Support Strength Gains: Research vs Marketing Claims Comparison
Marketing claims around MK-677 often conflate correlation with causation. Below is a side-by-side comparison of what the peer-reviewed literature actually demonstrates versus what supplement and peptide suppliers commonly claim. Builds muscle mass 1.1–2.7kg le
This comparison does not assign a generated winner or score.
- Marketing claims around MK-677 often conflate correlation with causation. Below is a side-by-side comparison of what the peer-reviewed literature actually demonstrates versus what supplement and peptide suppliers commonly claim.
- Builds muscle mass
- 1.1–2.7kg lean mass increase over 12 months when combined with resistance training (JCEM 2008); minimal gains without training
- "Powerful muscle builder" or "gains without lifting"
- MK-677 amplifies training-induced hypertrophy but does not produce muscle growth in untrained individuals
- Increases strength
- 18% improvement in leg press 1RM over placebo in trained elderly participants (Journal of Applied Physiology); no strength improvement in sedentary groups
- "Rapid strength gains" or "steroid-like results"
- Strength improvements occur only when progressive overload training is present. The peptide accelerates adaptation timelines but doesn't replace training
- Boosts IGF-1 levels
- 60–90% increase in serum IGF-1 sustained across 24 months at 25mg daily (Annals of Internal Medicine)
- "Maximizes anabolic hormone levels"
- IGF-1 elevation is consistent and significant, but elevated IGF-1 alone does not cause hypertrophy without mechanical tension
- Improves recovery
- 50% increase in stage 4 sleep duration; reduced subjective fatigue and faster force recovery post-training (Journal of Applied Physiology)
- "Instant recovery" or "train twice as hard"
- Recovery improvements are meaningful and allow for higher training frequency, but do not eliminate the need for rest and periodisation
- Fat loss effects
- Modest reductions in visceral adipose tissue in some studies; no direct lipolytic mechanism identified
- "Burns fat while you sleep"
- MK-677 increases appetite significantly via ghrelin pathway. Fat loss requires caloric deficit despite improved body composition signals